Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of galectin-3-targeted therapeutics for patients with MASH cirrhosis and portal hypertension, today announced it has appointed Henry ...

Galectin Therapeutics (NASDAQ:GALT) hosted a virtual key opinion leader (KOL) event to discuss belapectin as a potential ...

Researchers from The University of Osaka find that chronic liver congestion is linked to severe liver diseases through a specific signaling pathway in ...

Learn how beta-blockers, including carvedilol, can be used in advanced liver disease to manage portal hypertension and reduce ...

Patients treated with microwave ablation experienced significantly fewer postoperative complications and shorter hospital stays.

Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of galectin-3-targeted therapeutics for patients with MASH cirrhosis and portal hypertension ...

Chronic pancreatitis is now recognized as a complex fibroinflammatory disorder involving genetic, environmental, and ...

THIRUVANANTHAPURAM: Dhriya, a six-month-old baby born with a life-threatening liver disease, has returned home healthy after ...

As the global burden of obesity, type 2 diabetes, and metabolic syndrome continues to rise, fatty liver disease has become one of the most prevalent ...

THIRUVANANTHAPURAM: Dhriya, a six-month-old baby born with a life-threatening liver disease, has returned home healthy after a successful transplant made possib ...

As the global burden of obesity, type 2 diabetes, and metabolic syndrome continues to rise, fatty liver disease has become ...

T'puram: Six-month-old Dhriya, who was born with a life-threatening liver disease, successfully recovered after undergoing a ...